Clinical trial of a new anti-bradykinin, anti-inflammatory drug, ketoprofen (19.583 r.p.) in migraine prophylaxis.
D000293:Adolescent; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001593:Benzyl Compounds / Q000627:therapeutic use*; D001920:Bradykinin / Q000037:antagonists & inhibitors; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D008881:Migraine Disorders / Q000517:prevention & control*; D010666:Phenylpropionates / Q000627:therapeutic use*; D010919:Placebos
D000893:Anti-Inflammatory Agents; D001593:Benzyl Compounds; D010666:Phenylpropionates; D010919:Placebos; D001920:Bradykinin